Dr. John Noseworthy joined the board of directors of consulting firm AlixPartners.
Noseworthy is the former president and CEO of the Mayo Clinic, one of the largest and most prestigious not-for-profit academic health systems in the U.S. He retired from the Mayo Clinic at the end of 2018.
Noseworthy is the former president and CEO of the Mayo Clinic, one of the largest and most prestigious not-for-profit academic health systems in the U.S. He retired from the Mayo Clinic at the end of 2018.
Prior to his appointment as CEO in 2009, Noseworthy served as chair of the Department of Neurology, medical director of the Department of Development and vice chair of the Mayo Clinic Rochester Executive Board. He specialized in multiple sclerosis and spent more than two decades designing and conducting controlled clinical trials.
“I am delighted to welcome John to the AlixPartners board,” said Simon Freakley, CEO of AlixPartners. “At the time he was appointed CEO, the Mayo Clinic, along with many other health care organizations, was suffering the effects of a nationwide recession. John’s leadership and innovation played a key part in transforming Mayo’s profitability, as well as driving consistent high performance in health care quality, safety, and research, and championing the latest technology. The recently published Newsweek article ‘The 10 Best Hospitals in the World’ ranks Mayo Clinic #1, a true testament to John’s leadership legacy. John’s unique experience brings a valuable perspective to our board as we continue to grow AlixPartners.”
Noseworthy currently sits on the board of directors of UnitedHealth Group and Merck & Co. He previously served as health governor with the World Economic Forum.
